BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12082626)

  • 1. Chromatin remodeling factor encoded by ini1 induces G1 arrest and apoptosis in ini1-deficient cells.
    Ae K; Kobayashi N; Sakuma R; Ogata T; Kuroda H; Kawaguchi N; Shinomiya K; Kitamura Y
    Oncogene; 2002 May; 21(20):3112-20. PubMed ID: 12082626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.
    Lee S; Cimica V; Ramachandra N; Zagzag D; Kalpana GV
    Cancer Res; 2011 May; 71(9):3225-35. PubMed ID: 21521802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mammalian SWI/SNF complex and the control of cell growth.
    Muchardt C; Yaniv M
    Semin Cell Dev Biol; 1999 Apr; 10(2):189-95. PubMed ID: 10441072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle.
    Versteege I; Medjkane S; Rouillard D; Delattre O
    Oncogene; 2002 Sep; 21(42):6403-12. PubMed ID: 12226744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. INI1 expression induces cell cycle arrest and markers of senescence in malignant rhabdoid tumor cells.
    Reincke BS; Rosson GB; Oswald BW; Wright CF
    J Cell Physiol; 2003 Mar; 194(3):303-13. PubMed ID: 12548550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB.
    Betz BL; Strobeck MW; Reisman DN; Knudsen ES; Weissman BE
    Oncogene; 2002 Aug; 21(34):5193-203. PubMed ID: 12149641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of the INI1 tumor suppressor does not impair the expression of multiple BRG1-dependent genes or the assembly of SWI/SNF enzymes.
    Doan DN; Veal TM; Yan Z; Wang W; Jones SN; Imbalzano AN
    Oncogene; 2004 Apr; 23(19):3462-73. PubMed ID: 14990991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumor suppressor hSNF5/INI1 modulates cell growth and actin cytoskeleton organization.
    Medjkane S; Novikov E; Versteege I; Delattre O
    Cancer Res; 2004 May; 64(10):3406-13. PubMed ID: 15150092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function.
    Cheng SW; Davies KP; Yung E; Beltran RJ; Yu J; Kalpana GV
    Nat Genet; 1999 May; 22(1):102-5. PubMed ID: 10319872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knock down of hSNF5/Ini1 causes cell cycle arrest and apoptosis in a p53-dependent manner.
    Kato H; Honma R; Sanda T; Fujiwara T; Ito E; Yanagisawa Y; Imai J; Okamoto T; Watanabe S
    Biochem Biophys Res Commun; 2007 Sep; 361(3):580-5. PubMed ID: 17669367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumour suppressor hSNF5/INI1 controls the differentiation potential of malignant rhabdoid cells.
    Albanese P; Belin MF; Delattre O
    Eur J Cancer; 2006 Sep; 42(14):2326-34. PubMed ID: 16908131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromatin-remodeling factor INI1/hSNF5/BAF47 is involved in activation of the colony stimulating factor 1 promoter.
    Pan X; Song Z; Zhai L; Li X; Zeng X
    Mol Cells; 2005 Oct; 20(2):183-8. PubMed ID: 16267391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased DNA damage sensitivity and apoptosis in cells lacking the Snf5/Ini1 subunit of the SWI/SNF chromatin remodeling complex.
    Klochendler-Yeivin A; Picarsky E; Yaniv M
    Mol Cell Biol; 2006 Apr; 26(7):2661-74. PubMed ID: 16537910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RhoA-dependent regulation of cell migration by the tumor suppressor hSNF5/INI1.
    Caramel J; Quignon F; Delattre O
    Cancer Res; 2008 Aug; 68(15):6154-61. PubMed ID: 18676838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of hSNF5/INI1/BAF47 detected in rhabdoid cell lines and primary rhabdomyosarcomas but not Wilms' tumors.
    DeCristofaro MF; Betz BL; Wang W; Weissman BE
    Oncogene; 1999 Dec; 18(52):7559-65. PubMed ID: 10602515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5.
    Zhang ZK; Davies KP; Allen J; Zhu L; Pestell RG; Zagzag D; Kalpana GV
    Mol Cell Biol; 2002 Aug; 22(16):5975-88. PubMed ID: 12138206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors.
    Caramel J; Medjkane S; Quignon F; Delattre O
    Oncogene; 2008 Mar; 27(14):2035-44. PubMed ID: 17922027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. INI1 induces interferon signaling and spindle checkpoint in rhabdoid tumors.
    Morozov A; Lee SJ; Zhang ZK; Cimica V; Zagzag D; Kalpana GV
    Clin Cancer Res; 2007 Aug; 13(16):4721-30. PubMed ID: 17699849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of E1 and hSNF5 proteins stimulates replication of human papillomavirus DNA.
    Lee D; Sohn H; Kalpana GV; Choe J
    Nature; 1999 Jun; 399(6735):487-91. PubMed ID: 10365963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia.
    Grand F; Kulkarni S; Chase A; Goldman JM; Gordon M; Cross NC
    Cancer Res; 1999 Aug; 59(16):3870-4. PubMed ID: 10463572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.